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http:WHAT THIS PAPER ADDS
Patients with peripheral arterial disease, carotid stenosis, and aortic aneurysm have a high risk of coronary heart
disease. The prevalence of potentially treatable, silent coronary artery disease (CAD) in these patients is un-
known. Computed tomography and adenosine perfusion magnetic resonance imaging allow non-invasive
evaluation of coronary stenosis and myocardial perfusion. This is one of the ﬁrst studies to assess the preva-
lence of silent CAD in patients with stenotic and aneurysmatic vascular disease. The results support the concept
that atherosclerosis can have regional expression and non-expression, and therefore is not always systemic.
Performing large-scale studies in patients with extra-cardiac arterial disease is complicated by the fact that many
of these patients are already known with clinical CAD. This may explain the lack of studies on non-invasive
cardiac imaging in this patient group, and adds to the value of this study.Objective: Patients with extra-cardiac arterial disease (ECAD) are at high risk of coronary artery disease (CAD).
Prevalence of silent, signiﬁcant CAD in patients with stenotic or aneurysmal ECAD was examined. Early detection
and treatment may reduce CAD mortality in this high-risk group.
Materials and methods: ECAD patients without cardiac complaints underwent computed tomography (CT) for
calcium scoring, coronary CT angiography (cCTA) if calcium score was 1,000 or under, and adenosine perfusion
magnetic resonance imaging (APMR) if there was no left main stenosis. Signiﬁcant CAD was deﬁned as calcium
score over 1,000, cCTA-detected coronary stenosis of at least 50% lumen diameter, and/or APMR-detected
inducible myocardial ischemia. In cases of left main stenosis (or equivalent) or myocardial ischemia, patients
were referred to a cardiologist.
Results: The prevalence of signiﬁcant CAD was 56.8% (95% CI 47.5 to 66.0). One-hundred and eleven patients
were included. Eighty-four patients (76%) had stenotic ECAD, and 27 (24%) had aneurysmal disease. In patients
with stenotic ECAD, signiﬁcant coronary stenosis was present in 32 (38%) and inducible ischemia in eight (12%).
Corresponding results in aneurysmal ECAD were eight (30%) and two (11%), respectively (p for difference >.05).
Sixteen (19%) patients with stenotic and six (22%) with aneurysmal ECAD were referred to a cardiologist, with
subsequent cardiac intervention in seven (44%) and three (50%), respectively (both p >.05).
Conclusions: Patients with stenotic or aneurysmal ECAD have a high prevalence of silent, signiﬁcant CAD.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 30 March 2013, Accepted 27 August 2013, Available online 5 September 2013
Keywords: Coronary artery disease, Peripheral artery disease, Computed tomography, Magnetic resonance
imaging, PrevalenceINTRODUCTION
Extra-cardiac arterial disease (ECAD) is common in the
Western population, with a prevalence of 29% in peopleresponding author. R. Vliegenthart, Department of Radiology, Uni-
of Groningen, University Medical Center Groningen, Hanzeplein 1,
x 30001, 9700 RB, The Netherlands.
il address: r.vliegenthart@umcg.nl (R. Vliegenthart).
-5884/$ e see front matter  2013 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2013.08.013aged over 50 years.1 ECAD can be divided into stenotic and
aneurysmal disease. In ECAD patients, coronary artery dis-
ease (CAD) is the major cause of death.2e4 Compared with
individuals without ECAD, patients with ECAD have over ﬁve
times increased mortality risk, with an annual mortality rate
of over 3%, mostly as a result of coronary heart disease.5 In
patients undergoing vascular surgery, cardiac death ac-
counts for 45e67% of the operative mortality (3.9%).6 In
view of the high cardiac mortality in ECAD patients, early
detection and evidence-based treatment of silent, severe
CAD could potentially improve prognosis.
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zation can reduce the mortality risk in cases of signiﬁcant
CAD, even in patients without cardiac complaints. The
Coronary Artery Surgery Study showed an increased survival
rate from 57% to 88% for coronary artery bypass graft
surgery (CABG) compared with medical management in
patients with silent severe CAD.7 In the Asymptomatic
Cardiac Ischemia Pilot study, the 2-year mortality in patients
with silent signiﬁcant CAD was 1.1% for coronary revascu-
larization compared with 6.6% in cases of conservative
treatment.8 More recently, the CONFIRM registry (Coronary
CT Angiography EvaluatioN For Clinical Outcomes: An In-
teRnational Multicenter Registry) conﬁrmed a 2-year mor-
tality reduction for coronary revascularization compared
with conservative treatment (5.3% to 2.3%) in patients with
silent, severe CAD.9
In cases of severe CAD with or without symptoms, inva-
sive treatment with percutaneous coronary intervention
(PCI) or CABG is recommended.10,11 This is considered
particularly appropriate in patients at high risk (annual
mortality risk >3%),11 including ECAD patients. In ECAD, the
survival beneﬁt of coronary revascularization therapy has
mainly been investigated in patients scheduled for elective
vascular surgery. A study in 1,000 patients with invasive
coronary angiography reported improved 5-year survival if
CABG for silent, severe CAD was performed prior to major
vascular surgery (survival 86e92% for patients with CABG,
compared with 62e69% in those with indication for CABG,
but who did not undergo surgery).6 In a recent randomized
trial in patients undergoing carotid endarteriectomy, half of
the 426 patients were screened preoperatively by invasive
coronary angiography.12 Silent, severe CAD was detected
and revascularized in 31%. In the screened group, no pa-
tient (0%) died in the 30 days postoperatively, versus two
(4.2%) in the non-screened group. A randomized trial with
208 patients admitted for elective major vascular surgery
showed a higher 4-year coronary event-free survival in high-
risk patients undergoing preoperative coronary angiography
and revascularization, compared with those without (86.6%
vs. 69.6%, respectively).13
The exact prevalence of silent coronary stenosis and
myocardial ischemia in the overall population of patients
with stenotic or aneurysmal ECAD is unknown. As coronary
angiography is an invasive procedure with some risk of
morbidity and mortality, this procedure is generally only
performed when there is strong suspicion of CAD.
With new imaging modalities, CAD can be detected non-
invasively. Computed tomography (CT) without contrast
agent depicts the amount of coronary calcium, expressed as
a calcium score. Contrast-enhanced coronary CT angiog-
raphy (cCTA) can detect coronary luminal narrowing with
high diagnostic accuracy,14 while adenosine perfusion
magnetic resonance imaging (APMR) can evaluate the
functional signiﬁcance of coronary stenosis on the
myocardium under stress. APMR is more sensitive than
nuclear single-photon emission CT for detecting myocardial
ischemia, with the additional advantage of lack of radia-
tion.15e17 Non-invasive detection and subsequenttreatment of silent, severe CAD could lower CAD mortality
in ECAD patients in the future.
This study was performed to assess the prevalence of
silent CAD in cardiac asymptomatic patients with stenotic
and aneurysmal ECAD using non-invasive imaging
techniques.
MATERIALS AND METHODS
Patients
The GROUND2 study is a prospective multicenter study.18
Patients were recruited from departments of vascular sur-
gery at the University Medical Center Groningen and
Deventer Hospital. Patients were eligible if aged 50 years or
older and diagnosed with symptomatic ECAD (peripheral
artery obstructive disease [PAOD], carotid artery stenosis,
or aortic aneurysm) by a vascular surgeon. PAOD was
deﬁned by an ankle-brachial index of 0.7 or below, or pre-
vious surgical treatment. Carotid artery disease was deﬁned
as a stenosis of at least 50% lumen diameter stenosis as
diagnosed by ultrasonography (Acuson Antares, Siemens
Medical Solutions, Forchheim, Germany) or previous surgi-
cal treatment. Aortic aneurysm was deﬁned as a maximum
aortic diameter of at least 3 cm, measured in any direction,
detected by ultrasonography or CT (Deﬁnition, Siemens
Medical Solutions, Forchheim, Germany) or previous surgi-
cal treatment. If patients had stenotic and aneurysmal
ECAD, they were classiﬁed according to the most limiting
disease. The most limiting disease was considered the dis-
ease which (had) needed surgical treatment.
Exclusion criteria were history or complaints of symp-
tomatic CAD, unable to sustain a breath-hold for 25 sec-
onds, asthma, contra-indications to APMR examination,
contra-indications to adenosine, unable to remain in su-
pine position for at least 60 minutes, signiﬁcant aortic valve
stenosis, contra-indications to iodine contrast agent, renal
insufﬁciency (serum creatinine 120 mmol/L), severe
arterial hypertension (>220/120 mmHg), extreme obesity
(body mass index [BMI] >40 kg/m2), severe physical dete-
rioration as a result of concomitant disease, or inability to
give informed consent.
The study was approved by the local institutional review
boards. All patients gave written informed consent.
In the current investigation, only patients from the Uni-
versity Medical Center Groningen were included, as inclu-
sion at the latter center is still ongoing and the inclusion
rate at the latter center has so far been low, which could
introduce bias. A ﬂow chart of the study is given in Fig. 1. Of
the invited patients, over 70% agreed to participate. The
primary endpoints were deﬁned as signiﬁcant CAD (calcium
score >1,000), cCTA-detected coronary stenosis of at least
50%, or APMR-detected perfusion defects. Secondary
endpoint was referral to a cardiologist.
At baseline, patients completed a questionnaire on ECAD,
risk factors, medication use, medical history, and family
history (ﬁrst-degree relatives <60 years). Height, weight,
and blood pressure were measured. Total cholesterol, high-
density lipoproteins (HDL), low-density lipoproteins (LDL),
Figure 1. Flow chart with the study design and numbers of patients. ECAD: extra-cardiac arterial disease; CT: computed tomography; MRI:
magnetic resonance imaging.
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C-reactive protein (hsCRP) were measured at the local
laboratory. Hypertension was classiﬁed as systolic blood
pressure of at least 140 mmHg and/or diastolic blood
pressure of at least 90 mmHg, or medication for hyper-
tension. Dyslipidemia was classiﬁed as LDL cholesterol
>4.0 mmol/L, HDL cholesterol <1.2 mmol/L (female) or
<1.0 mmol/L (male), triglycerides >4.0 mmol/L, or current
lipid-lowering medication. Diabetes was classiﬁed as fasting
plasma glucose >7.0 mmol/L, known diabetes or medica-
tion for diabetes. Also an electrocardiogram (ECG) was
performed.
CCTA imaging
A dual-source CT scanner was used (Deﬁnition, Siemens
Medical Solutions, Forchheim, Germany).
First, a non-contrast-enhanced calcium score was per-
formed, using prospective ECG-triggering, starting 15 mm
cranial of the most superior coronary artery to 15 mm
caudal of the inferior border of the heart. Calcium score
calculation was performed according to Agatston.19 Next,
cCTA was performed using a standardized protocol. The
following scanning parameters were used: slice acquisi-
tion 64  2  0.6 mm, gantry rotation time 330 ms, tube
voltage 120 kV, BMI-adapted tube current (Care Dose).
Calcium scoring was used as scout radiograph. A beta-
blocker (metoprolol 5e20 mg, depending on heart rate)was administered intravenously to patients with a heart
rate over 65 bpm, under blood pressure monitoring.
Nitroglycerine was administered sublingually. Heart rate
and ECG were continuously monitored. As contrast ma-
terial iomeprol (Iomeron 400, 400 mg/mL, Bracco, Buck-
inghamshire, UK) was used at a ﬂow rate adjusted for
BMI.
Analysis of calcium scoring and cCTA was performed by
the attending radiologist, with at least 5 years experience in
cardiac imaging. According to clinical practice, a single
radiologist read the cCTA; cCTA acquisition and evaluation
were performed prior to APMR. In a 15-segment modiﬁed
American Heart Association classiﬁcation, all segments, in-
dependent of image quality, were evaluated visually. Seg-
ments were classiﬁed as having signiﬁcant stenosis when
there was at least 50% lumen diameter reduction. Patients
did not undergo cCTA if the calcium score exceeded 1,000.
APMR imaging
APMR was performed with a 1.5-Tesla scanner (Siemens
Medical Solutions, Forchheim, Germany). Patients were
instructed to refrain from caffeine 24 hours prior to ex-
amination. Medication interfering with adenosine was
stopped 5 days prior to examination. During the procedure,
ECG was continuously monitored. Blood pressure and heart
rate were recorded at baseline and every minute during
adenosine infusion.
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standard orientations of the heart, three parallel short-axis
slices (basal, mid-papillary, and apical) were planned for
perfusion imaging. Hyperemia was induced by continuous
intravenous infusion of 140 mg/kg/min adenosine. After 3
minutes, a bolus of gadolinium contrast material (infusion
rate and contrast material deﬁned by local practice) was
injected, followed by perfusion imaging. Minimally 5 mi-
nutes after perfusion images, MR sequences were repeated
for rest imaging. Ten minutes after the last gadolinium in-
jection, delayed contrast enhancement images were ac-
quired to assess possible myocardial infarctions.
Analysis of the APMR was performed by the attending
radiologist, with at least 5 years experience in cardiac im-
aging, using a 16-segment model. APMR was considered
positive if a perfusion abnormality was present in at least
two segments at consecutive planes during adenosine
stress imaging, with normalization at rest.Table 1. Baseline characteristics of all patients and comparison of ba
extra-cardiac artery disease.
Baseline characteristics All patients
(n ¼ 111)
Age (years) 65.2  7.7
Gender (male) 84 (75.7%)
Body mass Index 25.8 [23.2e28.4]
Hypertension 92 (82.9%)
Systolic blood pressure (mmHg) 141  24
Diastolic blood pressure (mmHg) 78  11
Dyslipidemia 104 (93.7%)
Total cholesterol (mmol/L) 4.7  1.9
Triglycerides (mmol/L) 2.06  1.88
HDL cholesterol (mmol/L) 1.3  0.4
LDL cholesterol (mmol/L) 2.7  0.9
Diabetes mellitus 15 (13.5%)
Glucose (mmol/L) 6.0  1.9
Creatinine (mmol/L) 80  18
High-sensitive CRP (mg/L) 2.1 [0.9e7.0]
Smoking
Current 37 (33.3%)
Past 65 (58.6%)
Never 9 (8.1%)
Previous vascular intervention 59 (53.2%)
PAOD
Previous surgical treatment
Current ankle brachial index
Current Fontaine 1
Current Fontaine 2
Current Fontaine 3
Current Fontaine 4
Carotid arterial disease
Previous surgical treatment
Symptomatic
Asymptomatic
Abdominal aortic aneurysm
Previous surgical treatment
Diameter not surgically treated
aneurysms (mm)
Values are mean  SD, median [interquartile range] or number of sub
lipoprotein; CRP: C-reactive protein; PAOD: peripheral artery obstructivReferral to cardiologist
In the GROUND2 study, we used current guidelines to
establish criteria for referral to a cardiologist for further
work-up and treatment.10,20 Patients were referred to a
cardiologist if a left main coronary artery stenosis or
equivalent (stenosis in proximal left anterior descending
artery and circumﬂex artery) was detected on cCTA, or if
APMR showed signs of reversible myocardial ischemia. In
case of incidental non-cardiac ﬁndings, patients were
referred to a dedicated physician. Invasive coronary
angiography was performed according to standard pro-
cedures using a transfemoral or transradial approach.
Multiple projections were obtained as deemed necessary
by the angiographer. Coronary angiography images were
assessed visually for diameter stenosis; no fractional ﬂow
reserve measurement was performed. Further work-up
and treatment choice was left to the discretion of the
cardiologist.seline characteristics in patients with stenotic versus aneurysmal
Stenotic
(n ¼ 84)
Aneurysmal
(n ¼ 27)
p
64.3  7.6 67.9  7.3 .03
61 (72.6%) 23 (85.2%) .08
25.2 [23.0e27.6] 26.4 [23.8e29.1] .24
72 (85.7%) 20 (74.1%) .16
142  24 134  25 .13
78  10 79  11 .67
78 (92.6%) 26 (96.3%) .52
4.7  1.0 4.6  1.3 .59
1.92  1.71 2.47  2.33 .20
1.3  0.4 1.2  0.4 .13
2.8  0.9 2.6  1.0 .37
14 (16.7%) 1 (3.7%) .09
6.1  2.1 5.6  1.0 .22
79  17 84  21 .24
1.9 [0.8e6.2] 3.8 [1.1e11.8] .045
.17
32 (38.1%) 5 (18.5%)
46 (57.1%) 19 (70.4%)
6 (7.1%) 3 (11.1%)
43 (51.2%) 16 (59.3%) .47
68 (81.0%) e
33 (48.5%) e
0.64  0.19 e
3 (4.4%) e
53 (77.9%) e
5 (7.4%) e
7 (10.3%) e
16 (19.0%) e
12 (75.0%) e
14 (87.5%) e
2 (12.5%) e
27 (100%)
e 16 (59.3%)
e 58  21
(range 33e100)
jects (percentage). HDL: High density lipoprotein; LDL: Low density
e disease. P-values <0.05 (signiﬁcant difference) are shown in bold.
Figure 2. Distribution of calcium score categories in stenotic and
aneurysmal extra-cardiac arterial disease (ECAD).
Table 3. Results from non-invasive imaging and cardiologist.
All patients
(n ¼ 111)
Stenotic
(n ¼ 84)
Aneurysmal
(n ¼ 27)
p
Computed
tomography
111 (100%) 84 (100%) 27 (100%)
Calcium
score
223.4
[33.4e850.2]
239.5
[48.4e991.8]
209.5
[26.8e457.0]
.21
Coronary CT
angiography
.88
No calcium
or stenosis
8 (7.2%) 6 (7.1%) 2 (7.4%)
No
signiﬁcant
stenosis
40 (36.0%) 29 (34.5%) 11 (40.7%)
Signiﬁcant
stenosis
40 (36.0%) 32 (38.1%) 8 (29.6%)
Calcium
score >
1,000 AU
23 (20.7%) 17 (20.2%) 6 (22.2%)
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Patients with stenotic ECAD (PAOD, carotid stenosis) were
grouped and compared with patients with aneurysmal
ECAD. Descriptive statistics were calculated as mean with
standard deviation or median with interquartile range and
absolute numbers and percentages in case of dichotomous
variables. The Student t test was used for normally
distributed, Kruskal-Wallis test for non-normally distributed
and the chi-square test for categorical variables. All statis-
tical analyses were performed using PASW Statistics version
18.0.3 (SPSS Inc, Chicago, IL, USA). All statistical tests are
two-sided and a p value of <.05 was considered to be
statistically signiﬁcant. The study had 80% power to deter-
mine a prevalence of 30% CAD as compared with 20% in the
overall population.6
RESULTS
Between December 2009 and March 2012, 111 patients
were included. In total, 68 patients had PAOD, 16 carotid
stenosis, and 27 abdominal aortic aneurysm. Of the patients
with PAOD, three were asymptomatic following surgery, the
remainder had at least Fontaine 2. Carotid stenosis was
symptomatic in 14 of 16 patients (87.5%). Of the patients
with an aortic aneurysm, 59.3% had been interventionally
treated. General characteristics are shown in Table 1.
Ninety percent of the patients with stenotic ECAD had at
least two risk factors, versus 81% of the patients with
aneurysmal ECAD (p ¼ .21).
Table 2 shows characteristics regarding family history.
Aneurysmal ECAD was more prevalent in families of pa-
tients with aortic aneurysm, whereas there was a tendency
(p ¼ 0.15) for higher prevalence of stenotic ECAD in families
of patients with stenotic ECAD.
CT was performed in all patients. Median calcium score
was 239.5 for stenotic ECAD and 209.5 for aneurysmal ECAD
(p ¼ .21). This is shown in Fig. 2. Twenty-three patients did
not undergo cCTA because their calcium scores were above
1,000. The results from cCTA were not signiﬁcantly different
between the two groups of patients (Table 3).Table 2. Baseline characteristics of all patients and comparison of
familial history in patients with stenotic versus aneurysmal extra-
cardiac artery disease.
Familial history All patients
(n ¼ 111)
Stenotic
(n ¼ 84)
Aneurysmal
(n ¼ 27)
p
High blood pressure 51 (45.9%) 39 (46.2%) 12 (44.4%) .86
Diabetes 25 (22.5%) 18 (21.4%) 7 (25.9%) .62
High cholesterol 35 (31.5%) 30 (35.7%) 5 (18.5%) .09
Stroke 15 (13.5%) 10 (11.9%) 5 (18.5%) .38
Myocardial
infarction
23 (20.7%) 19 (22.6%) 4 (14.8%) .38
Intermittent
claudication
31 (27.9%) 24 (28.6%) 7 (25.9%) .79
Dilatation of an
artery
9 (8.1%) 2 (2.4%) 7 (25.9%) <.01
Narrowing of an
artery
18 (16.2%) 16 (19.0%) 2 (7.4%) .15
Values are number of subjects (percentage).
Magnetic
resonance
imaging
83 (74.8%) 65 (77.4%) 18 (66.7%) .41
No ischemia 73 (88.0%) 57 (87.7%) 16 (88.9%)
Ischemia 10 (12.0%) 8 (12.3%) 2 (11.1%)
Cardiologist 22 (19.8%) 16 (19.0%) 6 (22.2%) .66
Invasive
angiography
16 (72.7%) 13 (81.3%) 3 (50.0%)
Conservative
treatment
9 (40.9%) 6 (37.5%) 3 (50.0%)
Intervention 10 (45.5%) 7 (43.7%) 3 (50.0%)
PCI 7 (70.0%) 7 (100%) 0 (0.0%)
CABG 2 (20.0%) 0 (0.0%) 2 (66.7%)
Other 1 (10.0%) 0 (0.0%) 1 (33.3%)
No treatment
possible
3 (14.2%) 3 (18.8%) 0 (0.0%)
Values are median [interquartile range] or number of subjects
(percentage). CT: computed tomography; AU: Agatston units;
PCI: percutaneous coronary intervention; CABG: coronary artery
bypass graft.
Table 4. Reasons for not performing adenosine perfusion magnetic
resonance imaging (APMR).
APMR not performed 28
 Not possible (i.e. aortic valvular stenosis,
aortic stent)
11
 Zero calcium score and no coronary plaque 8
 Primary referral to cardiologist after CT 4
 Refusal to undergo APMR 3
 Endpoint reached (death or myocardial
infarction)
2
CT: computed tomography.
European Journal of Vascular and Endovascular Surgery Volume 46 Issue 6 p. 680e689 December/2013 685After cCTA or calcium scoring, APMR was performed in 83
patients (74.8%; Table 4). Ischemia was present in eight
patients (12.3%) with stenotic ECAD and in two patients
(11.1%) with aneurysmal ECAD (p ¼ .41). The prevalence of
silent severe CAD was 56.8% (95% CI 47.5 to 66.0). The
waiting period between CT and APMR ranged from 1 to 6
months (70% <2 months).
In total, 22 patients were referred to a cardiologist
(Table 5). There was no signiﬁcant difference in referral
percentage between the two groups of patients. Six pa-
tients with positive cCTA and nine patients with positive
APMR underwent diagnostic coronary angiography. One
patient did not have a signiﬁcant stenosis on invasive cor-
onary angiography. Of patients referred to the cardiologist,
nine received a coronary intervention (42.9%). Two patients
were advised to undergo surgery, but preferred PCI. Three
more patients had a severe coronary stenosis without
possibility for intervention. They were treated by maximum
conservative treatment. Further details are shown in
Table 3. Figs. 3 and 4 show examples of referred patients.
Of the two patients referred with aortic valve stenosis, this
was severe in one. This patient was treated by transcatheter
aortic valve implantation. In one patient with a surgically
corrected aortic aneurysm, a new aneurysm was found. Two
patients had pulmonary lesions, comprising granulomas and
previously unknown sarcoidosis. No malignancies were
found.DISCUSSION
This is one of the ﬁrst studies in extra-cardiac arterial dis-
ease patients assessing the presence of asymptomatic CAD
using non-invasive screening. In ECAD patients without
cardiac symptoms or history, we found a high percentage of
silent, severe CAD on non-invasive imaging. Referral to aTable 5. Reasons for referral to cardiologist.
Referral cardiologist 22
 Extreme high calcium score 1
 Left main coronary artery stenosis 1
 Signiﬁcant stenosis cCTA, without possibility
of APMR
4
 Aortic valvular stenosis 2
 Perfusion defect APMR 10
 Atrial myxoma 1
 Cardiac complaints 3
Values are absolute numbers. cCTA: coronary computed
tomography angiography; APMR: adenosine perfusion magnetic
resonance imaging.cardiologist because of severe CAD was deemed necessary
in nearly one-ﬁfth of all patients, resulting in coronary
intervention in 9.0% of all patients. CT showed signiﬁcant
coronary stenosis in one-third, while an additional 21% of
patients had a very high calcium score (>1,000). This does
not imply CAD is present in all patients with ECAD. There
was a small, but distinct group of patients without any
coronary calciﬁcation or stenosis (7.2%).
ECAD patients have a high risk of coronary events. Leng
et al. found that 7% of patients with ECAD suffered a
myocardial infarction within 5 years in the Edinburgh Artery
Study, a cohort study of 1,592 subjects.21 In a large study,
1,000 patients with either stenotic or aneurysmal arterial
disease, considered for elective vascular reconstruction,
underwent invasive coronary angiography. Approximately
30% of the patients had signiﬁcant CAD, warranting coro-
nary revascularization. The authors concluded that non-
invasive cardiac screening could be important to assess
the necessity for invasive coronary angiography.6,22
Little is known about the prevalence of severe, silent
CAD. This is mainly because previously, invasive coronary
angiography was the only method to detect coronary ste-
nosis. This procedure is not without complications and
therefore not usually performed in patients without clinical
signs of CAD. Only recently, CT and MRI have emerged as
non-invasive imaging methods for imaging of the coronary
arteries and myocardium.
A previous study (n ¼ 3,263) on the association between
ECAD and CAD, examined with intravascular ultrasound,
revealed that patients with ECAD had more extensive and
calciﬁed CAD, impaired arterial remodeling and greater dis-
ease progression, compared with patients without ECAD.23
This suggests that patients with ECAD could have a more
aggressive formof systemic atherosclerosis. ECADmayactually
directly promote the development and progression of CAD.
Twomechanisms can be suggested. First, ECAD limitsmobility,
not only in patients with PAOD, but also in other forms of
ECAD. This may lead to a lower frequency of exercise-induced
cardiac symptoms in ECAD patients with CAD. Second, ECAD
could have a direct relation with myocardial ischemia through
impaired peripheral endothelial function with reduced vaso-
dilatation and vasoconstriction in response to stress.24,25 A
beneﬁcial effect from risk factor reduction on atherosclerosis
progression was demonstrated by Hussein et al.23 Risk factor
modiﬁcation with lifestyle changes such as smoking cessation
and optimal medical treatment with statins, beta-blockade
and anti-platelet therapy is recommended, especially in pa-
tients with several cardiac risk factors undergoing high-risk
vascular surgery, although only perioperatively for aneurysm
surgery.26,27 Unfortunately, adherence to the guidelines
regarding risk factor reduction is often performed less reliably
in patients with ECAD than in patients with proven CAD.24,25
The Coronary Artery Revascularization Prophylaxis study
showed no overall survival beneﬁt from preoperative coro-
nary revascularization before elective vascular surgery in
patients with single- or multi-vessel CAD. However, preop-
erative coronary revascularization did positively impact sur-
vival in patients with unprotected left main coronary artery
Figure 3. Example of a 76-year-old patient with peripheral artery obstructive disease (PAOD). (A) Coronary computed tomography (CT)
angiography image. White arrow points to a mixed plaque in the proximal left anterior descending artery, with stenosis of the lumen.
Calcium score was 553. (B) Short axis image of the adenosine perfusion magnetic resonance imaging (MRI) examination. White arrows
point to a subendocardial perfusion defect in the septal wall, during stress. The perfusion defect was not present in the rest series, thus
indicating inducible ischemia. (C) Invasive coronary angiography image of the left coronary arteries. Black arrow points to a signiﬁcant
stenosis, corresponding with the location seen on CT. (D) Invasive coronary angiography image after intervention. Good result after
percutaneous coronary intervention with stent placement.
686 M.A.M. den Dekker et al.stenosis, which was present in 4.6% of patients.28 Another
study stated that in patients undergoing elective vascular
surgery, risk stratiﬁcation screening for CAD is indicated,
possibly with non-invasive imaging.26 Patients who have
clinical atherosclerotic disease, such as ECAD, are also
considered to be at high risk of CAD.29 Drawback of the
available risk stratiﬁcation models for cardiovascular risk is
the relative inaccuracy, for example to predict perioperative
death after elective open abdominal aortic aneurysm
repair.30 Thus, non-invasive imaging of CAD can be an
important addition to risk stratiﬁcation in appropriately
selected ECAD patients.
The value of coronary assessment prior to carotid
endarteriectomy has previously been studied. Illuminati
et al.12 found a reduction of postoperative cardiac
ischemic events when invasive coronary angiography, if
necessary combined with percutaneous coronary inter-
vention, was performed preoperatively. This was alsobeneﬁcial in cardiac asymptomatic patients, and supports
cardiac screening prior to major vascular surgery.22 Coro-
nary stenosis was found in about a third of patients, in line
with our results. Although in this study only preoperative
patients were included, we evaluated a broader range of
ECAD patients. It is unknown if screening for CAD in the
entire population of ECAD patients is recommendable.
Current guidelines do not advocate routine CAD imaging
in all ECAD patients. Although our study shows silent,
severe CAD in a considerable proportion of ECAD patients,
a beneﬁcial effect of CAD screening by non-invasive im-
aging on occurrence of coronary events in the following
years still needs to be proven. For this, large trials should
be performed.
There are limitations to our study that must be
mentioned. First of all, the study population was relatively
small. Inclusion of vascular patients for our cardiac imaging
study was complicated by the fact that many of these
Figure 4. Example of a 68-year-old patient with peripheral artery obstructive disease (PAOD). (A) Coronary computed tomography (CT)
angiography. White arrow points to a soft plaque in the proximal right coronary artery, narrowing the lumen more than 50%. (B) Short axis
image of the adenosine perfusion magnetic resonance imaging (MRI) examination. White arrow points to a perfusion defect of the inferior
wall during stress. This perfusion was not present in rest, indicating reversible ischemia. (C) Invasive coronary angiography image of the
right coronary artery. The right coronary artery is proximally occluded (white arrow). No percutaneous intervention was possible at this
stage. Because of the asymptomatic status and good collateral circulation (visible as contrast ﬁlling distal to the occlusion), no surgery was
performed.
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likely that this at least partly explains the lack of studies on
non-invasive cardiac imaging in this patient group, and adds
to the value of the current study. We estimate that
approximately 10% of patients were considered suitable for
inclusion. It is probable that the setting of the tertiary,
university hospital contributed to low inclusion rate, as the
patients who are treated at this center are more often
complicated cases. Thus, it is likely that the inclusion rate
would be substantially higher in a general hospital. Sec-
ondly, although the two vascular patient groups are not
signiﬁcantly different in risk factors, they are different in
size. The group with aneurysmal vascular disease was
smaller. This can be explained by the fact that stenotic
atherosclerosis is much more prevalent in the vascular
surgery outpatient clinic, compared with aortic aneurysms.
Lastly, at this stage follow-up of the patient population is
not known.This study is one of the ﬁrst to demonstrate a high
prevalence of silent, severe coronary artery disease by non-
invasive imaging in patients with extra-cardiac arterial dis-
ease. The rate of CAD was not signiﬁcantly different in pa-
tients with stenotic compared with aneurysmal ECAD.
Further studies may show screening in these high-risk pa-
tients to be beneﬁcial.
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